TORCH lgM test panel and TORCH lgG test panel are rapid lateral flow test designed for the qualitative detection of the lgM and lgG antibodies to the following viruses in human serum/plasma specimens: Toxoplasmosis (TOXO), Cytomegalovirus(CMV), Rubella Virus Type 1(HSV-1) and Herpes Simplex Virus Type 2(HSV-2).
The acronym TORCH was introduced to highlight a group of viral diseases which affect the fetus and newborn, namely Toxoplasma gondii (TOXO), rubella virus (RV), cytomegalovirus(CMV), and herpes simplex viruses(HSV). These diseases often lead to a similar clinical picture which includes one or more of the following clinical signs: low birth weight, prematurity, purpura, jaundice, anemia, microcephaly, hydrocephaly, cerebral calcification, chorioretinitis, cataracts, microphthalmia, hearing impairment, mental retardation, autism and pneumonitis. The early diagnosis of TORCH infection is very important to avoid the symptoms and lesions.
